Exhibit 10.2

 

ASSIGNMENT OF INTEREST

 

WHEREAS, W. KEITH R. WATSON, a citizen of United Kingdom residing in Rosarito
Beach, Baja California, Mexico, has developed a new molecule, employing
combinations of fluorochemicals with suitable emulsifying agents, that is stable
at room temperatures and possesses enhanced oxygen carrying capacity and
overcomes the toxic reaction problem in the use of synthetic phospholipids in
substitute blood when fluorochemicals are used, therefore making it useful in
the synthesis of artificial blood,

 

AND WHEREAS, this new molecule is being readied for patent application in
Mexico, the United States, and world wide,

 

THEREFORE BE IT RESOLVED THAT, I do hereby assign to SINEQUONAN CORPORATION of
New Jersey, all interests, rights, and ownership of this new molecule, and all
improvements made thereon, for Twelve Million Six Hundred & Eighty Thousand
(12,680,000) shares of the stock of SINEQUONAN CORP., or not less that
seventy-two (72%) per cent of the issued and outstanding stock after the above
12,680,000 shares are issued.

 

EXECUTED THIS 19th DAY OF SEPTEMBER, 1990, in Rosarito Beach, Baja California,
Mexico.

 

WITNESS:

 

/s/

--------------------------------------------------------------------------------

 

SIGNED:

 

/s/

--------------------------------------------------------------------------------

   

ROBERT LARSON

     

W. KEITH R. WATSON